ERBB2 and breast carcinoma: Several systems have been developed to deliver tumor-associated antigens into the body, for example whole tumor cell vaccines, dendritic cell vaccines, viral vector vaccines, and peptide vaccines, the last being the focus of clinical investigations among high-risk women for prevention of HER2-positive breast cancer.